Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bjartveit K., Waaler H. Some evidence of the efficacy of mass BCG vaccination. Bull World Health Organ. 1965;33(3):289–319. [PMC free article] [PubMed] [Google Scholar]
- Genz H. Entwicklung der Säuglingstuberkulose in Deutschland im ersten Jahr nach Aussetzen der ungezielten BCG-Impfung. Dtsch Med Wochenschr. 1977 Sep 9;102(36):1271–1273. doi: 10.1055/s-0028-1105491. [DOI] [PubMed] [Google Scholar]
- Lotte A., Wasz-Höckert O., Poisson N., Dumitrescu N., Verron M., Couvet E. BCG complications. Estimates of the risks among vaccinated subjects and statistical analysis of their main characteristics. Adv Tuberc Res. 1984;21:107–193. [PubMed] [Google Scholar]
- Nunn P. P., McAdam K. P. Mycobacterial infections and AIDS. Br Med Bull. 1988 Jul;44(3):801–813. doi: 10.1093/oxfordjournals.bmb.a072284. [DOI] [PubMed] [Google Scholar]
- Rieder H. L., Cauthen G. M., Bloch A. B., Cole C. H., Holtzman D., Snider D. E., Jr, Bigler W. J., Witte J. J. Tuberculosis and acquired immunodeficiency syndrome--Florida. Arch Intern Med. 1989 Jun;149(6):1268–1273. [PubMed] [Google Scholar]
- Romanus V. Childhood tuberculosis in Sweden. An epidemiological study made six years after the cessation of general BCG vaccination of the newborn. Tubercle. 1983 Jun;64(2):101–110. doi: 10.1016/0041-3879(83)90034-x. [DOI] [PubMed] [Google Scholar]
- Romanus V. Swedish experiences 12 years after the cessation of general BCG vaccination of newborns in 1975. Bull Int Union Tuberc Lung Dis. 1988 Dec;63(4):34–38. [PubMed] [Google Scholar]
- Rouillon A., Waaler H. BCG vaccination and epidemiological situation: a decision making approach to the use of BCG. Adv Tuberc Res. 1976;19:64–126. [PubMed] [Google Scholar]
- Sanders R., Dickson M. G. BCG vaccination scars: an avoidable problem? Br Med J (Clin Res Ed) 1982 Dec 11;285(6356):1679–1680. doi: 10.1136/bmj.285.6356.1679. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Selwyn P. A., Hartel D., Lewis V. A., Schoenbaum E. E., Vermund S. H., Klein R. S., Walker A. T., Friedland G. H. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med. 1989 Mar 2;320(9):545–550. doi: 10.1056/NEJM198903023200901. [DOI] [PubMed] [Google Scholar]
- Springett V. H., Darbyshire J. H., Nunn A. J., Sutherland I. Changes in tuberculosis notification rates in the white ethnic group in England and Wales between 1953 and 1983. J Epidemiol Community Health. 1988 Dec;42(4):370–376. doi: 10.1136/jech.42.4.370. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stilwell J. A. Benefits and costs of the schools' BCG vaccination programme. Br Med J. 1976 Apr 24;1(6016):1002–1004. doi: 10.1136/bmj.1.6016.1002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Styblo K., Meijer J. Impact of BCG vaccination programmes in children and young adults on the tuberculosis problem. Tubercle. 1976 Mar;57(1):17–43. doi: 10.1016/0041-3879(76)90015-5. [DOI] [PubMed] [Google Scholar]
- Sutherland I., Springett V. H. Effectiveness of BCG vaccination in England and Wales in 1983. Tubercle. 1987 Jun;68(2):81–92. doi: 10.1016/0041-3879(87)90023-7. [DOI] [PubMed] [Google Scholar]
- Sutherland I., Springett V. H. The effects of the scheme for BCG vaccination of schoolchildren in England and Wales and the consequences of discontinuing the scheme at various dates. J Epidemiol Community Health. 1989 Mar;43(1):15–24. doi: 10.1136/jech.43.1.15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Trnka L., Dankova D. First experience with the project of discontinuation of BCG primovaccination in newborns in Czechoslovakia. Bull Int Union Tuberc Lung Dis. 1988 Dec;63(4):39–39. [PubMed] [Google Scholar]
- WALLGREN A. Should mass vaccination with BCG be discontinued in Scandinavia? Acta Paediatr. 1955 May;44(3):237–253. doi: 10.1111/j.1651-2227.1955.tb04136.x. [DOI] [PubMed] [Google Scholar]